Mangalam Drugs And Organics Ltd. Share Price

Pharmaceuticals & Drugs

Mangalam Drugs And Organics Ltd. (INR)80.49-0.7 (-0.8%)

Exchange ScripsBSE532637NSEMANGALAMISININE584F01014

Stock Performance

Fundamentals

Technicals

Shareholding Patterns

Financials

Similar Stocks

Trendline of performance -

Mangalam Drugs And Organics Ltd. Performance

Market performance

Open price81.11

High81.67

Volumes6574

Prev Close80.49

Low80

Closing date2025-06-18

Historical performance

1 Year High144.99

3 Year High173.00

5 Year High196.95

1 Year Low70.10

3 Year Low70.10

5 Year Low61.00

Mangalam Drugs And Organics Ltd. Fundamentals

Company Valuation

Market Cap (₹Cr)

NaN

Face Value (₹)

P/E Ratio

Dividend Yield

N/A

Mangalam Drugs And Organics Ltd. Investment Returns

1 Year

-28.8%

3 Years

-43.6%

5 Years

25.8%

10 Years

32.2%

Mangalam Drugs And Organics Ltd. Technicals

Indicators	Value	Signal
5-DMA	81.06	Bearish
10-DMA	81.62	Bearish
20-DMA	81.29	Bearish
50-DMA	79.42	Bullish
100-DMA	86.71	Bearish
200-DMA	102.15	Bearish

Shareholding Pattern

Field	Mar-2025	Dec-2024	Sep-2024	Jun-2024	Mar-2024
Promoters	18	18	18	18	18
Foreign Investors	---	---	---	---	---
Domestic Investors	18	18	18	18	18
Public Investors	19679	19661	19490	19294	19155
Government	---	---	---	---	---

Mangalam Drugs And Organics Ltd. Financials

Below figures are in Rs. Crores

Particulars	Mar-2024
Other Income	1
Operating Profit	175
Interest	139
Depreciation	147
Profit Before Tax	-111
Consolidated Net Profit	-91
Adjusted EPS	-6

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2024
Share Capital	158
Total Reserves	1200
Minority Interest	---
Total Non-Current Liabilities	338
Total Liabilities	3337
Capital Work in Progress	---
Total Assets	3337

Cash Flow

Below figures are in Rs. Crores

Particulars	Mar-2024
Cash Flow from Operating Activities	39
Cash Flow from Investing Activities	-118
Cash Flow from Financing Activitie	52
Net Cash Inflow / Outflow	-27

Negative

Neutral

Positive

The stock has a PE ratio of -14.04.
3Y Stock Price CAGR of the stock is -17.3.
The stock has a beta of 1.1.
In the last financial year, the company had an EBITDA of ₹175 Million.
The company generated revenue of ₹3686 Million in the previous financial year.

Mangalam Drugs And Organics Ltd.

80.49-0.7 (-0.8%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 748396.1

No. of Shares: 9298.0

Performance:-25.2%

P/L: ₹-251603.9

Top Gainers

Symbol	Change%
EMIL	158.37(18%)
SILLYMONKS	18(14%)
OPTIEMUS	684.6(11%)
AAKASH	9.7(11%)
PFOCUS	130.98(10%)

Top Losers

Symbol	Change%
ORIENTCEM	253.7(-16%)
KBCGLOBAL	0.55(-11%)
SHAH	4.45(-10%)
MOBIKWIK	244.85(-9%)
HAVISHA	2.29(-9%)
SGL	16.62(-9%)
IKS	1703.4(-8%)
STLTECH	104.55(-7%)

Similar stocks

Ind-Swift Laboratories Ltd.

▲ 45.1

103.35

May 18 - June 18

Onesource Specialty Pharma Ltd.

▲ 37.5

2195

May 18 - June 18

Concord Biotech Ltd.

▲ 34

2008.9

May 18 - June 18

Pfizer Ltd.

▲ 31.3

5792.5

May 18 - June 18

Shilpa Medicare Ltd.

▲ 29.7

917.9

May 18 - June 18

Wockhardt Ltd.

▲ 29.2

1718.5

May 18 - June 18

Strides Pharma Science Ltd.

▲ 29.1

853.8

May 18 - June 18

Venus Remedies Ltd.

▲ 26.6

433.95

May 18 - June 18

Announcing Stock of the Month!